Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - flucloxacillin sodium monohydrate, quantity: 281.89 mg - capsule - excipient ingredients: methyl hydroxybenzoate; titanium dioxide; indigo carmine; gelatin; magnesium stearate; propyl hydroxybenzoate; purified water; propylene glycol; butan-1-ol; isopropyl alcohol; shellac; ethanol absolute; ammonia; potassium hydroxide - treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - flucloxacillin sodium monohydrate, quantity: 563.78 mg - capsule - excipient ingredients: indigo carmine; methyl hydroxybenzoate; propyl hydroxybenzoate; gelatin; magnesium stearate; titanium dioxide; purified water; propylene glycol; butan-1-ol; isopropyl alcohol; shellac; ethanol absolute; ammonia; potassium hydroxide - treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - flucloxacillin sodium monohydrate 27.2 mg/ml equivalent to flucloxacillin 25 mg/ml;  ; flucloxacillin sodium monohydrate 28.63 mg/ml equivalent to flucloxacillin 25 mg/ml - powder for syrup - 125 mg/5ml - active: flucloxacillin sodium monohydrate 27.2 mg/ml equivalent to flucloxacillin 25 mg/ml   excipient: ammonium glycyrrhizinate disodium edetate dihydrate erythrosine menthol flavour 17410157 pineapple flavour 17410011 saccharin sodium sodium benzoate sodium citrate dihydrate sucrose active: flucloxacillin sodium monohydrate 28.63 mg/ml equivalent to flucloxacillin 25 mg/ml excipient: citric acid monohydrate colloidal silicon dioxide disodium edetate dihydrate lemon flavour 17.41.0212 menthol flavour 17410157 saccharin sodium sodium benzoate sodium citrate sorbitol strawberry flavour 17.43.2172 xanthan gum - the treatment of infections due to gram-positive organisms, including infections caused by ?-lactamase producing staphylococci

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - flucloxacillin sodium monohydrate 54.4 mg/ml equivalent to flucloxacillin 50 mg/ml;  ; flucloxacillin sodium monohydrate 57.26 mg/ml equivalent to flucloxacillin 50 mg/ml - powder for syrup - 250 mg/5ml - active: flucloxacillin sodium monohydrate 54.4 mg/ml equivalent to flucloxacillin 50 mg/ml   excipient: ammonium glycyrrhizinate disodium edetate dihydrate erythrosine menthol flavour 17410157 pineapple flavour 17410011 saccharin sodium sodium benzoate sodium citrate dihydrate sucrose active: flucloxacillin sodium monohydrate 57.26 mg/ml equivalent to flucloxacillin 50 mg/ml excipient: citric acid monohydrate colloidal silicon dioxide disodium edetate dihydrate lemon flavour 17.41.0212 menthol flavour 17410157 saccharin sodium sodium benzoate sodium citrate sorbitol strawberry flavour 17.43.2172 xanthan gum - the treatment of infections due to gram-positive organisms, including infections caused by ?-lactamase producing staphylococci

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - flucloxacillin sodium monohydrate, quantity: 1088.1 mg (equivalent: flucloxacillin, qty 1000 mg) - injection, powder for - excipient ingredients: - for the treatment of confirmed or suspected staphylococcal infections and other gram-positive coccal infections. indications include pneumonia, osteomyelitis, skin and skin structure and wound infections, infected burns and cellulitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - flucloxacillin sodium monohydrate, quantity: 544.1 mg (equivalent: flucloxacillin, qty 500 mg) - injection, powder for - excipient ingredients: - for the treatment of confirmed or suspected staphylococcal infections and other gram-positive coccal infections. indications include pneumonia, osteomyelitis, skin and skin structure and wound infections, infected burns and cellulitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - flucloxacillin sodium monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - flucloxacillin sodium monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - flucloxacillin sodium monohydrate -

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - flucloxacillin sodium monohydrate 272.6mg equivalent to flucloxacillin 250 mg;   - capsule - 250 mg - active: flucloxacillin sodium monohydrate 272.6mg equivalent to flucloxacillin 250 mg   excipient: colloidal silicon dioxide gelatin magnesium stearate